These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36428562)

  • 1. In Silico Identification of Genes Associated with Breast Cancer Progression and Prognosis and Novel Therapeutic Targets.
    Uchida S; Sugino T
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-4513 promotes breast cancer progression through targeting TRIM3.
    Li Y; Zhu H; Wang J; Qian X; Li N
    Am J Transl Res; 2019; 11(4):2431-2438. PubMed ID: 31105849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The initial expression alterations occurring to transcription factors during the formation of breast cancer: Evidence from bioinformatics.
    Dong X; Yang Y; Xu G; Tian Z; Yang Q; Gong Y; Wu G
    Cancer Med; 2022 Mar; 11(5):1371-1395. PubMed ID: 35037412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Analysis of the Expression and Prognostic Value of SPINT1/2 in Breast Carcinoma.
    Wu Q; Yin G; Luo J; Zhang Y; Ai T; Tian J; Jin Y; Lei J; Liu S
    Front Endocrinol (Lausanne); 2021; 12():665666. PubMed ID: 34381422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High methionyl-tRNA synthetase expression predicts poor prognosis in patients with breast cancer.
    Jin Q; Liu G; Wang B; Li S; Ni K; Wang C; Ren J; Zhang S; Dai Y
    J Clin Pathol; 2020 Dec; 73(12):803-812. PubMed ID: 32404475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic analysis of the expression and prognosis relevance of FBXO family reveals the significance of FBXO1 in human breast cancer.
    Liu Y; Pan B; Qu W; Cao Y; Li J; Zhao H
    Cancer Cell Int; 2021 Feb; 21(1):130. PubMed ID: 33622332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double Agent:
    Ye T; Feng J; Wan X; Xie D; Liu J
    Cancer Manag Res; 2020; 12():3891-3902. PubMed ID: 32547225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The subtype-specific molecular function of SPDEF in breast cancer and insights into prognostic significance.
    Ye T; Li J; Feng J; Guo J; Wan X; Xie D; Liu J
    J Cell Mol Med; 2021 Aug; 25(15):7307-7320. PubMed ID: 34191390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Prognostic Biomarkers and Molecular Targets Among JAK Family in Breast Cancer.
    Liu F; Wu H
    J Inflamm Res; 2021; 14():97-114. PubMed ID: 33469338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative Analysis of the Expression Levels and Prognostic Values for NEK Family Members in Breast Cancer.
    Gao WL; Niu L; Chen WL; Zhang YQ; Huang WH
    Front Genet; 2022; 13():798170. PubMed ID: 35368696
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening of the novel immune-suppressive biomarkers of TMED family and whether knockdown of TMED2/3/4/9 inhibits cell migration and invasion in breast cancer.
    Fang Z; Song YX; Wo GQ; Zhou HL; Li L; Yang SY; Chen X; Zhang J; Tang JH
    Ann Transl Med; 2022 Dec; 10(23):1280. PubMed ID: 36618780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and prognosis analysis of mitochondrial ribosomal protein family in breast cancer.
    Lin X; Guo L; Lin X; Wang Y; Zhang G
    Sci Rep; 2022 Jun; 12(1):10658. PubMed ID: 35739158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Seven Cell Cycle-Related Genes with Unfavorable Prognosis and Construction of their TF-miRNA-mRNA regulatory network in Breast Cancer.
    Hong Z; Wang Q; Hong C; Liu M; Qiu P; Lin R; Lin X; Chen F; Li Q; Liu L; Wang C; Chen D
    J Cancer; 2021; 12(3):740-753. PubMed ID: 33403032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High SET Domain Bifurcated 1 (SETDB1) Expression Predicts Poor Prognosis in Breast Carcinoma.
    Zhou Z; Wu B; Tang X; Yang W; Zou Q; Wang H
    Med Sci Monit; 2020 Apr; 26():e922982. PubMed ID: 32305991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
    Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z
    Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR‑425‑5p is associated with poor prognosis in patients with breast cancer and promotes cancer cell progression by targeting PTEN.
    Xiao S; Zhu H; Luo J; Wu Z; Xie M
    Oncol Rep; 2019 Dec; 42(6):2550-2560. PubMed ID: 31638259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and analysis of dysregulated fatty acid metabolism genes in breast cancer subtypes.
    Yousuf U; Sofi S; Makhdoomi A; Mir MA
    Med Oncol; 2022 Oct; 39(12):256. PubMed ID: 36224382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of key differentially expressed genes between ER-positive/HER2-negative breast cancer and ER-negative/HER2-negative breast cancer using integrated bioinformatics analysis.
    Gan S; Dai H; Li R; Liu W; Ye R; Ha Y; Di X; Hu W; Zhang Z; Sun Y
    Gland Surg; 2020 Jun; 9(3):661-675. PubMed ID: 32775256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Analysis of the Expression and Prognosis for Tripartite Motif-Containing Genes in Breast Cancer.
    Ning L; Huo Q; Xie N
    Front Genet; 2022; 13():876325. PubMed ID: 35928444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of super-enhancer-driven tumor suppressor gene RCAN1.4 expression promotes the malignancy of breast carcinoma.
    Deng R; Huang JH; Wang Y; Zhou LH; Wang ZF; Hu BX; Chen YH; Yang D; Mai J; Li ZL; Zhang HL; Huang Y; Peng XD; Feng GK; Zhu XF; Tang J
    Mol Cancer; 2020 Aug; 19(1):122. PubMed ID: 32771023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.